DoW Rare Cancers Idea Development Award
OpenDefense Health Agency Contracting Activity - DHACA · Opportunity number HT942526RCRPIDA
Eligibility
Nonprofits are listed as eligible applicants.
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Description
Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) promotes ideas that are ready for further development and have the potential to yield high-impact findings and new avenues of investigation.
Distinctive Features:
• The RCRP encourages applicants to include an exploratory aim or sub-aim to support any necessary discovery-driven research.
• Preliminary data with disease-specific rationale are required. However, these data do not necessarily need to originate from studies of the proposed rare cancer type(s)/subtype(s) under study.
• Research should have high potential impact on rare cancers and the patient community.
Funding
| Total program funding | $7,350,000 |
|---|---|
| Award floor | Not listed |
| Award ceiling | Not listed |
| Category | Science and Technology |
| Assistance listing | 12.420 |
Official sources
Last verified on Grants.gov Nov 4, 2026. Grantvello is not affiliated with Grants.gov or Defense Health Agency Contracting Activity - DHACA. The notice on Grants.gov is the binding text.